CVE-2025-54074

Cherry Studio is Vulnerable to OS Command Injection during Connection with a Malicious MCP Server

Description

Cherry Studio is a desktop client that supports for multiple LLM providers. From versions 1.2.5 to 1.5.1, Cherry Studio is vulnerable to OS Command Injection during a connection with a malicious MCP server in HTTP Streamable mode. Attackers can setup a malicious MCP server with compatible OAuth authorization server endpoints and trick victims into connecting it, leading to OS command injection in vulnerable clients. This issue has been patched in version 1.5.2.

Category

7.7
CVSS
Severity: High
CVSS 4.0 •
EPSS 0.50%
Affected: CherryHQ cherry-studio
Published at:
Updated at:

References

Link Tags
https://github.com/CherryHQ/cherry-studio/security/advisories/GHSA-8xr5-732g-84px
https://github.com/CherryHQ/cherry-studio/commit/40f9601379150854826ff3572ef7372fb0acdc38

Frequently Asked Questions

What is the severity of CVE-2025-54074?
CVE-2025-54074 has been scored as a high severity vulnerability.
How to fix CVE-2025-54074?
To fix CVE-2025-54074, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-54074 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-54074 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-54074?
CVE-2025-54074 affects CherryHQ cherry-studio.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.